Skip to main content
Erschienen in: Journal of Neurology 6/2009

01.06.2009 | Original Communication

Sex differences in the prognostic value of the lipid profile after the first ischemic stroke

verfasst von: E. Cuadrado-Godia, J. Jiménez-Conde, A. Ois, A. Rodríguez-Campello, E. García-Ramallo, J. Roquer

Erschienen in: Journal of Neurology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Post-stroke levels of total cholesterol (TC) appear to be negatively associated with stroke mortality. Statin pretreatment might affect this association. Sex differences in the prognostic value of the lipid profile have not yet been studied. We have evaluated the impact of TC, high- and low-density lipoprotein (HDL and LDL, respectively), and triglyceride (TG) levels on the 3-month outcome after a first ischemic stroke (IS) according to sex and previous statin use. The study group consisted of a hospital-based cohort of consecutive patients with a diagnosis of first IS. Poor outcome was defined as a modified Rankin Scale (mRS) score ≥3 at 90 days. The odds ration (OR) for poor prognosis was analyzed for each sex using logistic regression models adjusted for vascular risk factors and statin pretreatment. A total of 591 patients were included in the analysis (318 men). The predictors of a 90-day poor outcome were age and initial NIH Stroke Scale (NIHSS) score in women, and age, initial NIHSS, smoking, atrial fibrillation, and thrombolytic treatment in men. In women, none of the lipids studied affected the 90-day prognosis. Men falling in the last quintile of TC [OR: 0.68 95% confidence interval (95% CI) 0.52–0.88; p = 0.004] and LDL (OR 0.74, 95% CI 0.56–0.98; p = 0.04) have better outcome than men in the first quintile. Adjusting for statin pretreatment did not change the results. The results indicated that an association between poststroke lipids and prognosis may vary by sex. In women, lipids were not associated with the outcome; in men, lower TC and LDL were associated with worse prognosis. These differences can not be explained by statin use and require further research.
Literatur
1.
Zurück zum Zitat Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41PubMed Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41PubMed
2.
Zurück zum Zitat Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, Molina CA, Montaner J (2007) Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 38:1076–1078PubMedCrossRef Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, Molina CA, Montaner J (2007) Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 38:1076–1078PubMedCrossRef
3.
4.
Zurück zum Zitat Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69(9):904–910PubMedCrossRef Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69(9):904–910PubMedCrossRef
5.
Zurück zum Zitat von Büdingen HC, Baumgartner RW, Baumann CR, Rousson V, Siegel AM, Georgiadis D (2008) Serum cholesterol levels do not influence outcome or recovery in acute ischemic stroke. Neurol Res 30(1):4–82 von Büdingen HC, Baumgartner RW, Baumann CR, Rousson V, Siegel AM, Georgiadis D (2008) Serum cholesterol levels do not influence outcome or recovery in acute ischemic stroke. Neurol Res 30(1):4–82
6.
Zurück zum Zitat Colivicchi F, Bassi A, Santini M, Caltagirone C (2007) Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 38(10):7–2652CrossRef Colivicchi F, Bassi A, Santini M, Caltagirone C (2007) Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 38(10):7–2652CrossRef
7.
Zurück zum Zitat Dale KM, Coleman CI, Shah SA, Patel AA, Kluger J, White CM (2007) Impact of gender on statin efficacy. Curr Med Res Opin 23(3):74–565CrossRef Dale KM, Coleman CI, Shah SA, Patel AA, Kluger J, White CM (2007) Impact of gender on statin efficacy. Curr Med Res Opin 23(3):74–565CrossRef
8.
Zurück zum Zitat Dyker AG, Weir CJ, Lees KR (1997) Influence of cholesterol on survival after stroke: retrospective study. Br Med J 314:1584–1588 Dyker AG, Weir CJ, Lees KR (1997) Influence of cholesterol on survival after stroke: retrospective study. Br Med J 314:1584–1588
9.
Zurück zum Zitat Elkind MS, Flint AC, Sciacca RR, Sacco RL (2005) Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 65:253–258PubMedCrossRef Elkind MS, Flint AC, Sciacca RR, Sacco RL (2005) Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 65:253–258PubMedCrossRef
10.
Zurück zum Zitat Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, American Heart Association American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113:e873–e923PubMedCrossRef Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, American Heart Association American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113:e873–e923PubMedCrossRef
11.
Zurück zum Zitat Goldstein LB, Samsa GP (1997) Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 28:307–310PubMed Goldstein LB, Samsa GP (1997) Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 28:307–310PubMed
12.
Zurück zum Zitat Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masiá R, Cordón F, Sala J, Juvinyà D, Cerezo C, Fitó M, Vila J, Covas MI, Marrugat J (2007) Trends in cardiovascular risk factor prevalence (1995–2000–2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil 14(5):9–653CrossRef Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masiá R, Cordón F, Sala J, Juvinyà D, Cerezo C, Fitó M, Vila J, Covas MI, Marrugat J (2007) Trends in cardiovascular risk factor prevalence (1995–2000–2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil 14(5):9–653CrossRef
13.
Zurück zum Zitat Horenstein RB, Smith DE, Mosca L (2002) Cholesterol predicts stroke mortality in the Women’s Pooling Project. Stroke 33:1863–1868PubMedCrossRef Horenstein RB, Smith DE, Mosca L (2002) Cholesterol predicts stroke mortality in the Women’s Pooling Project. Stroke 33:1863–1868PubMedCrossRef
14.
Zurück zum Zitat Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP (1993) Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 87:728–737PubMed Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP (1993) Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 87:728–737PubMed
15.
Zurück zum Zitat Ois A, Cuadrado-Godia E, Jimenez-Conde J, Gomis M, Rodriguez-Campello A, Martinez-Rodriguez JE, Munteis E, Roquer J (2007) Early arterial study in the prediction of mortality after acute ischemic stroke. Stroke 38:2085–2089PubMedCrossRef Ois A, Cuadrado-Godia E, Jimenez-Conde J, Gomis M, Rodriguez-Campello A, Martinez-Rodriguez JE, Munteis E, Roquer J (2007) Early arterial study in the prediction of mortality after acute ischemic stroke. Stroke 38:2085–2089PubMedCrossRef
16.
Zurück zum Zitat Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK (2007) Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 38:2646–2651PubMedCrossRef Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK (2007) Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 38:2646–2651PubMedCrossRef
17.
Zurück zum Zitat Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (2008) Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. doi:10.1016/ijcard.2008.08.001 Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (2008) Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. doi:10.​1016/​ijcard.​2008.​08.​001
18.
Zurück zum Zitat Pikija S, Milevcic D, Trkulja V, Kidemet-Piskac S, Pavlicek I, Sokol N (2006) Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol 55:89–92PubMedCrossRef Pikija S, Milevcic D, Trkulja V, Kidemet-Piskac S, Pavlicek I, Sokol N (2006) Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol 55:89–92PubMedCrossRef
19.
Zurück zum Zitat Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A and for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators (2008) Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 39(6):8–1779CrossRef Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A and for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators (2008) Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 39(6):8–1779CrossRef
20.
Zurück zum Zitat Roquer J, Campello AR, Gomis M (2003) Sex differences in first-ever acute stroke. Stroke 34:1581–1585PubMedCrossRef Roquer J, Campello AR, Gomis M (2003) Sex differences in first-ever acute stroke. Stroke 34:1581–1585PubMedCrossRef
21.
Zurück zum Zitat Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P (2005) Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 65:1198–1202PubMedCrossRef Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P (2005) Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 65:1198–1202PubMedCrossRef
22.
Zurück zum Zitat Sheikh K (2008) Total cholesterol, severity of stroke, and all-cause mortality. Stroke 39(3):e61–e62PubMedCrossRef Sheikh K (2008) Total cholesterol, severity of stroke, and all-cause mortality. Stroke 39(3):e61–e62PubMedCrossRef
23.
Zurück zum Zitat Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607PubMed Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607PubMed
24.
Zurück zum Zitat Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J (2000) Better outcome after stroke with higher serum cholesterol levels. Neurology 54:1944–1949PubMed Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J (2000) Better outcome after stroke with higher serum cholesterol levels. Neurology 54:1944–1949PubMed
25.
Zurück zum Zitat Weir CJ, Sattar N, Walters MR, Lees KR (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 16:76–82PubMedCrossRef Weir CJ, Sattar N, Walters MR, Lees KR (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 16:76–82PubMedCrossRef
Metadaten
Titel
Sex differences in the prognostic value of the lipid profile after the first ischemic stroke
verfasst von
E. Cuadrado-Godia
J. Jiménez-Conde
A. Ois
A. Rodríguez-Campello
E. García-Ramallo
J. Roquer
Publikationsdatum
01.06.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 6/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5059-9

Weitere Artikel der Ausgabe 6/2009

Journal of Neurology 6/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.